Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.29

ANIK Q4 2016 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ANIKAnika Therapeutics, Inc.

$208M

Q4 2016 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$29M

Gross Profit

$21M73.8% margin

Operating Income

$13M44.4% margin

Net Income

$8M28.1% margin

EPS (Diluted)

$0.54

QoQ Revenue Growth

+11.4%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$4M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$240M

Total Liabilities

$17M

Stockholders' Equity

$223M

Cash & Equivalents

$104M

Revenue Segments

Orthobiologics

$24M86%

Surgical

$2M5%

Other

$1M4%

Dermal

$1M4%

Geographic Segments

UNITED STATES

$23M89%

Europe

$3M11%

← FY 2016 All Quarters Q1 2017 →